{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:31:41Z","timestamp":1784305901247,"version":"3.55.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11920-014-0541-1","type":"journal-article","created":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T21:51:58Z","timestamp":1422222718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Bipolar Disorder: Role of Immune-Inflammatory Cytokines, Oxidative and Nitrosative Stress and Tryptophan Catabolites"],"prefix":"10.1007","volume":"17","author":[{"given":"George","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"541_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/9780470976739.ch19","volume-title":"Textbook in psychiatric epidemiology","author":"KR Merinkangas","year":"2011","unstructured":"Merinkangas KR, Tohen M. Epidemiology of bipolar disorder in adults and children. In: Tsuang MT, Tohen MT, Jones PB, editors. Textbook in psychiatric epidemiology. Chichester: Wiley; 2011. p. 329\u201342."},{"issue":"1","key":"541_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-5380-2-18","volume":"2","author":"MP Leussis","year":"2012","unstructured":"Leussis MP, Madison JM, Petryshen TL. Ankyrin 3: genetic association with bipolar disorder and relevance to disease pathophysiology. Biol Mood Anxiety Disord. 2012;2(1):18.","journal-title":"Biol Mood Anxiety Disord"},{"issue":"5","key":"541_CR3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.b.32057","volume":"159B","author":"F Seifuddin","year":"2012","unstructured":"Seifuddin F et al. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(5):508\u201318.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"4","key":"541_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","volume":"47","author":"BN Frey","year":"2013","unstructured":"Frey BN et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry. 2013;47(4):321\u201332.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"541_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","volume":"29","author":"M Maes","year":"1995","unstructured":"Maes M et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995;29(2):141\u201352.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"541_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995;34(4):301\u20139.","journal-title":"J Affect Disord"},{"issue":"1","key":"541_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997;66(1):1\u201311.","journal-title":"Psychiatry Res"},{"issue":"4","key":"541_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","volume":"17","author":"AA Wadee","year":"2002","unstructured":"Wadee AA et al. Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002;17(4):175\u20139.","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"541_CR9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S1734-1140(13)71526-3","volume":"65","author":"G Anderson","year":"2013","unstructured":"Anderson G et al. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep. 2013;65(6):1647\u201354.","journal-title":"Pharmacol Rep"},{"issue":"5","key":"541_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14728222.2014.888417","volume":"18","author":"M Maes","year":"2014","unstructured":"Maes M et al. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets. 2014;18(5):495\u2013512.","journal-title":"Expert Opin Ther Targets"},{"key":"541_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S et al. Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev. 2014;45:46\u201362.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"541_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804\u201317.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1\u20133","key":"541_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2006.12.008","volume":"102","author":"AM Myint","year":"2007","unstructured":"Myint AM et al. Tryptophan breakdown pathway in bipolar mania. J Affect Disord. 2007;102(1\u20133):65\u201372.","journal-title":"J Affect Disord"},{"issue":"3","key":"541_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.b.30252","volume":"141B","author":"CM Nievergelt","year":"2006","unstructured":"Nievergelt CM et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(3):234\u201341.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"541_CR15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1751-7893.2011.00323.x","volume":"6","author":"A Duffy","year":"2012","unstructured":"Duffy A et al. Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic-pituitary-adrenal axis and immune system. Early Interv Psychiatry. 2012;6(2):128\u201337.","journal-title":"Early Interv Psychiatry"},{"issue":"5","key":"541_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bdi.12099","volume":"16","author":"M Berk","year":"2014","unstructured":"Berk M et al. Stage managing bipolar disorder. Bipolar Disord. 2014;16(5):471\u20137. This is a comprehensive analysis of recent conceptualizations of the neuroprogressive nature of bipolar disorder.","journal-title":"Bipolar Disord"},{"issue":"1","key":"541_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rbp.2012.09.001","volume":"35","author":"CS Gama","year":"2013","unstructured":"Gama CS et al. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr. 2013;35(1):70\u20134.","journal-title":"Rev Bras Psiquiatr"},{"issue":"12","key":"541_CR18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/0004867413499077","volume":"47","author":"S Rege","year":"2013","unstructured":"Rege S, Hodgkinson SJ. Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust N Z J Psychiatry. 2013;47(12):1136\u201351.","journal-title":"Aust N Z J Psychiatry"},{"key":"541_CR19","first-page":"3(4)","volume":"18","author":"J Westman","year":"2013","unstructured":"Westman J et al. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013;18:3(4).","journal-title":"BMJ Open"},{"issue":"4","key":"541_CR20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/13651501.2012.752012","volume":"17","author":"HA Yee","year":"2013","unstructured":"Yee HA, Loh HS, Ng CG. The prevalence and correlates of alcohol use disorder amongst bipolar patients in a hospital setting, Malaysia. Int J Psychiatry Clin Pract. 2013;17(4):292\u20137.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"11","key":"541_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11920-014-0499-z","volume":"16","author":"C Miller","year":"2014","unstructured":"Miller C, Bauer MS. Excess mortality in bipolar disorders. Curr Psychiatry Rep. 2014;16(11):499.","journal-title":"Curr Psychiatry Rep"},{"key":"541_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-010-2035-0","volume":"214","author":"JA Markham","year":"2011","unstructured":"Markham JA, Koenig JI. Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl). 2011;214:89\u2013106.","journal-title":"Psychopharmacology (Berl)"},{"issue":"2\u20133","key":"541_CR23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jad.2012.11.034","volume":"148","author":"N Hamdani","year":"2013","unstructured":"Hamdani N et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013;148(2\u20133):444\u20138.","journal-title":"J Affect Disord"},{"issue":"5","key":"541_CR24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.psyneuen.2012.08.005","volume":"38","author":"CH do Prado","year":"2013","unstructured":"do Prado CH et al. Reduced regulatory T cells are associated with higher levels of Th1\/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology. 2013;38(5):667\u201376. This is an interesting article showing significant changes in bipolar patients in regard to immune and intracellular signalling pathways.","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"541_CR25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1399-5618.2006.00359.x","volume":"8","author":"EM Knijff","year":"2006","unstructured":"Knijff EM et al. A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord. 2006;8(6):740\u201350.","journal-title":"Bipolar Disord"},{"issue":"6","key":"541_CR26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbi.2011.03.013","volume":"25","author":"RC Drexhage","year":"2011","unstructured":"Drexhage RC et al. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun. 2011;25(6):1206\u201313.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"541_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pnpbp.2008.11.011","volume":"33","author":"KC Torres","year":"2009","unstructured":"Torres KC et al. Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):229\u201334.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"541_CR28","first-page":"79","volume":"13","author":"A Abeer El-Sayed","year":"2006","unstructured":"Abeer El-Sayed A, Ramy HA. Immunological changes in patients with mania: changes in cell mediated immunity in a sample from Egyptian patients. Egypt J Immunol. 2006;13(1):79\u201385.","journal-title":"Egypt J Immunol"},{"issue":"9","key":"541_CR29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm K et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47(9):1119\u201333. This is an important meta-analysis of cytokine changes in bipolar disorder patients.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"541_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15\u201325. An important meta-analysis of cytokine changes across a range of studies involving bipolar disorder patients.","journal-title":"Biol Psychiatry"},{"key":"541_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00406-012-0327-6","volume":"263","author":"IG Barbosa","year":"2013","unstructured":"Barbosa IG et al. Chemokines in bipolar disorder: trait or state? Eur Arch Psychiatry Clin Neurosci. 2013;263:159\u201365.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"541_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","volume":"46","author":"IG Barbosa","year":"2012","unstructured":"Barbosa IG et al. Increased levels of adipokines in bipolar disorder. J Psychiatr Res. 2012;46:389\u201393.","journal-title":"J Psychiatr Res"},{"key":"541_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2014.02.005","volume":"564","author":"MG Soeiro-de-Souza","year":"2014","unstructured":"Soeiro-de-Souza MG et al. Lithium decreases plasma adiponectin levels in bipolar depression. Neurosci Lett. 2014;564:111\u20134.","journal-title":"Neurosci Lett"},{"issue":"2","key":"541_CR34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","volume":"150","author":"F Dickerson","year":"2013","unstructured":"Dickerson F et al. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord. 2013;150(2):456\u20139.","journal-title":"J Affect Disord"},{"issue":"5","key":"541_CR35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","volume":"30","author":"H Hsuchou","year":"2012","unstructured":"Hsuchou H et al. C-reactive protein increases BBB permeability: implications for obesity and neuroinflammation. Cell Physiol Biochem. 2012;30(5):1109\u201319.","journal-title":"Cell Physiol Biochem"},{"issue":"1\u20133","key":"541_CR36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2012.12.023","volume":"145","author":"S Hope","year":"2013","unstructured":"Hope S et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res. 2013;145(1\u20133):36\u201342.","journal-title":"Schizophr Res"},{"issue":"4","key":"541_CR37","first-page":"599","volume":"46","author":"A Remlinger-Molenda","year":"2012","unstructured":"Remlinger-Molenda A et al. Activity of selected cytokines in bipolar patients during manic and depressive episodes. Psychiatr Pol. 2012;46(4):599\u2013611.","journal-title":"Psychiatr Pol"},{"issue":"3","key":"541_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bdi.12164","volume":"16","author":"JW Hsu","year":"2014","unstructured":"Hsu JW et al. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study. Bipolar Disord. 2014;16(3):241\u20138.","journal-title":"Bipolar Disord"},{"key":"541_CR39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-244X-12-158","volume":"12","author":"T Cetin","year":"2012","unstructured":"Cetin T et al. Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms. BMC Psychiatry. 2012;12:158.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"541_CR40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","volume":"116","author":"E Brietzke","year":"2009","unstructured":"Brietzke E et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116(3):214\u20137.","journal-title":"J Affect Disord"},{"issue":"6","key":"541_CR41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","volume":"9","author":"A Ortiz-Dom\u00ednguez","year":"2007","unstructured":"Ortiz-Dom\u00ednguez A et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007;9(6):596\u2013602.","journal-title":"Bipolar Disord"},{"key":"541_CR42","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1038\/tp.2013.87","volume":"3","author":"K Becking","year":"2013","unstructured":"Becking K et al. The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry. 2013;3:e314.","journal-title":"Transl Psychiatry"},{"key":"541_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","volume":"166","author":"YM Bai","year":"2014","unstructured":"Bai YM et al. Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder. J Affect Disord. 2014;166:187\u201392.","journal-title":"J Affect Disord"},{"key":"541_CR44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2014.07.040","volume":"580","author":"A Wieck","year":"2014","unstructured":"Wieck A et al. Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder. Neurosci Lett. 2014;580:17\u201321.","journal-title":"Neurosci Lett"},{"key":"541_CR45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2013.12.042","volume":"157","author":"IG Barbosa","year":"2014","unstructured":"Barbosa IG et al. A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status. J Affect Disord. 2014;157:41\u20134.","journal-title":"J Affect Disord"},{"issue":"7","key":"541_CR46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","volume":"9","author":"EM Knijff","year":"2007","unstructured":"Knijff EM et al. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007;9(7):743\u201353.","journal-title":"Bipolar Disord"},{"issue":"1\u20133","key":"541_CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","volume":"104","author":"YK Kim","year":"2007","unstructured":"Kim YK et al. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104(1\u20133):91\u20135.","journal-title":"J Affect Disord"},{"key":"541_CR48","unstructured":"Nassar A, Azab AN. Effects of lithium on inflammation. ACS Chem Neurosci. In press."},{"key":"541_CR49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","volume":"21","author":"BI Goldstein","year":"2011","unstructured":"Goldstein BI et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Ch Adol Psychopharmacol. 2011;21:479\u201384.","journal-title":"J Ch Adol Psychopharmacol"},{"key":"541_CR50","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1038\/tp.2014.46","volume":"4","author":"P Brambilla","year":"2014","unstructured":"Brambilla P et al. Increased M1\/decreased M2 signature and signs of Th1\/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia. Transl Psychiatry. 2014;4:e406. Important data on changes in monocyte and T cell-associated cytokines in bipolar disorder patients.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"541_CR51","doi-asserted-by":"crossref","first-page":"e52010","DOI":"10.1371\/journal.pone.0052010","volume":"7","author":"SM Muxel","year":"2012","unstructured":"Muxel SM et al. NF-kB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-nacetyltransferase (AA-NAT) gene. PLoS ONE. 2012;7(12):e52010.","journal-title":"PLoS ONE"},{"issue":"12","key":"541_CR52","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jpsychires.2013.08.019","volume":"47","author":"IG Barbosa","year":"2013","unstructured":"Barbosa IG et al. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients. J Psychiatr Res. 2013;47(12):1949\u201354.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"541_CR53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/JCP.0b013e318270e5e2","volume":"32","author":"M Bartels","year":"2012","unstructured":"Bartels M et al. Valproic acid treatment is associated with altered leukocyte subset development. J Clin Psychopharmacol. 2012;32(6):832\u20134.","journal-title":"J Clin Psychopharmacol"},{"key":"541_CR54","doi-asserted-by":"crossref","first-page":"806162","DOI":"10.1155\/2014\/806162","volume":"2014","author":"H Himmerich","year":"2014","unstructured":"Himmerich H et al. Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro. Oxid Med Cell Longev. 2014;2014:806162.","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"541_CR55","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145711001969","volume":"15","author":"LP Niles","year":"2012","unstructured":"Niles LP et al. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int J Neuropsychopharmacol. 2012;15(9):1343\u201350.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"541_CR56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","volume":"36","author":"J S\u00f6derlund","year":"2011","unstructured":"S\u00f6derlund J et al. Elevation of cerebrospinal fluid interleukin-1\u03b2 in bipolar disorder. J Psychiatry Neurosci. 2011;36(2):114\u20138.","journal-title":"J Psychiatry Neurosci"},{"issue":"7","key":"541_CR57","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","volume":"16","author":"RC Shelton","year":"2011","unstructured":"Shelton RC et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011;16(7):751\u201362.","journal-title":"Mol Psychiatry"},{"key":"541_CR58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2014.05.056","volume":"576","author":"SG Bahna","year":"2014","unstructured":"Bahna SG et al. Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer\u2019s disease. Neurosci Lett. 2014;576:84\u20137.","journal-title":"Neurosci Lett"},{"issue":"5","key":"541_CR59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1871527313666140711091400","volume":"13","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M. Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders. CNS Neurol Disord Drug Targets. 2014;13(5):817\u201327. An important summary of the potential roles of local melatonin across a host of conditions, including bipolar disorder.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6","key":"541_CR60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/gps.4048","volume":"29","author":"FE Lotrich","year":"2014","unstructured":"Lotrich FE et al. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int J Geriatr Psychiatry. 2014;29(6):635\u201344.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"541_CR61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","volume":"28","author":"O Doganavsargil-Baysal","year":"2013","unstructured":"Doganavsargil-Baysal O et al. Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder. Hum Psychopharmacol. 2013;28(2):160\u20137.","journal-title":"Hum Psychopharmacol"},{"key":"541_CR62","unstructured":"Volkert J, et al. Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. Eur Neuropsychopharmacol. In press."},{"issue":"7","key":"541_CR63","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.comppsych.2014.06.001","volume":"55","author":"M Buoli","year":"2014","unstructured":"Buoli M et al. The impact of mood episodes and duration of illness on cognition in bipolar disorder. Compr Psychiatry. 2014;55(7):1561\u20136.","journal-title":"Compr Psychiatry"},{"issue":"5","key":"541_CR64","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.4088\/JCP.13m08625","volume":"75","author":"AR Rosa","year":"2014","unstructured":"Rosa AR et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75(5):e450\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"541_CR65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12017-010-8140-8","volume":"13","author":"JK Soczynska","year":"2011","unstructured":"Soczynska JK et al. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromol Med. 2011;13(2):93\u2013116.","journal-title":"Neuromol Med"},{"key":"541_CR66","unstructured":"Mesman E, et al. Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood. Bipolar Disord. In press."},{"issue":"23","key":"541_CR67","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.2174\/13816128113196660738","volume":"20","author":"G Anderson","year":"2014","unstructured":"Anderson G, Maes M. Oxidative\/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des. 2014;20(23):3812\u201347. A comprehensive review on the biological changes, and their interconnectedness, occurring in depression.","journal-title":"Curr Pharm Des"},{"key":"541_CR68","unstructured":"Aydemir O, et al. Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder: an empirical cross-sectional study. Rev Bras Psiquiatr. In press."},{"issue":"2","key":"541_CR69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/mp.2012.188","volume":"19","author":"A Versace","year":"2014","unstructured":"Versace A et al. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry. 2014;19(2):200\u20138. Important data showing an association of oxidative stress with changes in central white matter.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"541_CR70","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jnc.12316","volume":"127","author":"AC Andreazza","year":"2013","unstructured":"Andreazza AC et al. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. 2013;127(4):552\u201361.","journal-title":"J Neurochem"},{"key":"541_CR71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jad.2014.02.018","volume":"159","author":"CC Bortolasci","year":"2014","unstructured":"Bortolasci CC et al. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord. 2014;159:23\u201330. Important data that contributes to the biological differentiation of unipolar and bipolar depression.","journal-title":"J Affect Disord"},{"issue":"1","key":"541_CR72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pnpbp.2011.12.006","volume":"37","author":"U Banerjee","year":"2012","unstructured":"Banerjee U et al. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37(1):56\u201361.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"541_CR73","first-page":"680","volume":"5","author":"R Khairova","year":"2012","unstructured":"Khairova R et al. Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep. 2012;5(3):680\u20132.","journal-title":"Mol Med Rep"},{"issue":"2","key":"541_CR74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jpi.12026","volume":"54","author":"DX Tan","year":"2013","unstructured":"Tan DX et al. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes. J Pineal Res. 2013;54(2):127\u201338.","journal-title":"J Pineal Res"},{"key":"541_CR75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbr.2014.03.029","volume":"268","author":"CB Wilson","year":"2014","unstructured":"Wilson CB et al. Valproic acid effects in the hippocampus and prefrontal cortex in an animal model of post-traumatic stress disorder. Behav Brain Res. 2014;268:72\u201380.","journal-title":"Behav Brain Res"},{"issue":"7","key":"541_CR76","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S1461145713000047","volume":"16","author":"MG Soeiro-de-Souza","year":"2013","unstructured":"Soeiro-de-Souza MG et al. Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol. 2013;16(7):1505\u201312. An important article highlighting the changes occurring in neuroprogression in bipolar patients.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"541_CR77","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jpsychires.2011.01.016","volume":"45","author":"N Abe","year":"2011","unstructured":"Abe N et al. Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res. 2011;45(8):1106\u201312.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"541_CR78","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","volume":"45","author":"BS Fernandes","year":"2011","unstructured":"Fernandes BS et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res. 2011;45(8):995\u20131004.","journal-title":"J Psychiatr Res"},{"key":"541_CR79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/978-1-4614-3209-8_96","volume":"801","author":"PM Iuvone","year":"2014","unstructured":"Iuvone PM et al. N-acetylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain. Adv Exp Med Biol. 2014;801:765\u201371.","journal-title":"Adv Exp Med Biol"},{"key":"541_CR80","volume-title":"Metabolic syndrome and neurological disorders","author":"G Anderson","year":"2013","unstructured":"Anderson G, Maes M. Metabolic syndrome, Alzheimer\u2019s, schizophrenia and depression: role for leptin, melatonin, kynurenine pathways and neuropeptides. Chap 13. In: Farooqui T, Farooqui AA, editors. Metabolic syndrome and neurological disorders. Chichester, UK: Wiley; 2013."},{"issue":"11","key":"541_CR81","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jpsychires.2013.08.008","volume":"47","author":"AS Johansson","year":"2013","unstructured":"Johansson AS et al. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J Psychiatr Res. 2013;47(11):1815\u201323.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"541_CR82","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/mp.2013.11","volume":"19","author":"C Lavebratt","year":"2014","unstructured":"Lavebratt C et al. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression. Mol Psychiatry. 2014;19(3):334\u201341.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"541_CR83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bdi.12166","volume":"16","author":"EZ Reininghaus","year":"2014","unstructured":"Reininghaus EZ et al. Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report. Bipolar Disord. 2014;16(4):432\u201340. Preliminary data, but potentially of great importance, as the article highlights changes in tryptophan catabolites in bipolar patients.","journal-title":"Bipolar Disord"},{"key":"541_CR84","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2010.08.029","volume":"76","author":"G Anderson","year":"2011","unstructured":"Anderson G. Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination. Med Hypotheses. 2011;76:54\u201360.","journal-title":"Med Hypotheses"},{"key":"541_CR85","unstructured":"Stubbs B, et al. The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis. Acta Psychiatr Scand. In press."},{"issue":"2\u20133","key":"541_CR86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","volume":"196","author":"M Maes","year":"2012","unstructured":"Maes M, Rief W. Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res. 2012;196(2\u20133):243\u20139.","journal-title":"Psychiatry Res"},{"issue":"2","key":"541_CR87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/acps.12182","volume":"129","author":"G Anderson","year":"2014","unstructured":"Anderson G, Berk M, Maes M. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatr Scand. 2014;129(2):83\u201397.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"541_CR88","doi-asserted-by":"crossref","first-page":"e63564","DOI":"10.1371\/journal.pone.0063564","volume":"8","author":"D Hackel","year":"2013","unstructured":"Hackel D et al. The connection of monocytes and reactive oxygen species in pain. PLoS One. 2013;8(5):e63564.","journal-title":"PLoS One"},{"issue":"1","key":"541_CR89","first-page":"117","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol Lett. 2008;29(1):117\u201324. An article of considerable importance that highlights the role of the gut in driving inflammatory changes in mood disorders.","journal-title":"Neuroendocrinol Lett"},{"key":"541_CR90","unstructured":"Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. In press."},{"issue":"9","key":"541_CR91","doi-asserted-by":"crossref","first-page":"e107421","DOI":"10.1371\/journal.pone.0107421","volume":"9","author":"E Elamin","year":"2014","unstructured":"Elamin E et al. Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach. PLoS One. 2014;9(9):e107421.","journal-title":"PLoS One"},{"issue":"6","key":"541_CR92","first-page":"591","volume":"62","author":"PC Konturek","year":"2011","unstructured":"Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011;62(6):591\u20139.","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"541_CR93","doi-asserted-by":"crossref","first-page":"G95","DOI":"10.1152\/ajpgi.00074.2013","volume":"305","author":"A Sommansson","year":"2013","unstructured":"Sommansson A et al. Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo. Am J Physiol Gastrointest Liver Physiol. 2013;305(1):G95\u2013G105.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"541_CR94","doi-asserted-by":"crossref","first-page":"e96864","DOI":"10.1371\/journal.pone.0096864","volume":"9","author":"S Bala","year":"2014","unstructured":"Bala S et al. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLoS One. 2014;9(5):e96864.","journal-title":"PLoS One"},{"issue":"18","key":"541_CR95","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1093\/hmg\/dds227","volume":"21","author":"B Etain","year":"2012","unstructured":"Etain B et al. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum Mol Genet. 2012;21(18):4030\u20137.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"541_CR96","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.arcmed.2014.03.008","volume":"45","author":"HN Yu","year":"2014","unstructured":"Yu HN et al. Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch Med Res. 2014;45(3):195\u201320.","journal-title":"Arch Med Res"},{"issue":"2","key":"541_CR97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11011-012-9307-9","volume":"27","author":"G Anderson","year":"2012","unstructured":"Anderson G, Maes M. Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metab Brain Dis. 2012;27(2):113\u20139.","journal-title":"Metab Brain Dis"},{"issue":"7","key":"541_CR98","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2013.04.001","volume":"28","author":"R Robillard","year":"2013","unstructured":"Robillard R et al. Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry. 2013;28(7):412\u20136.","journal-title":"Eur Psychiatry"},{"issue":"6","key":"541_CR99","doi-asserted-by":"crossref","first-page":"10979","DOI":"10.3390\/ijms140610979","volume":"14","author":"RP Markus","year":"2013","unstructured":"Markus RP, Cecon E, Pires-Lapa MA. Immune-pineal axis: nuclear factor \u03baB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. Int J Mol Sci. 2013;14(6):10979\u201397.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"541_CR100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bdi.12196","volume":"16","author":"F Romo-Nava","year":"2014","unstructured":"Romo-Nava F et al. Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. Bipolar Disord. 2014;16(4):410\u201321. A very important article showing that melatonin can prevent the inflammatory and metabolic dysregulation associated with antipsychotic treatment of bipolar disorder.","journal-title":"Bipolar Disord"},{"key":"541_CR101","doi-asserted-by":"crossref","unstructured":"Redlich R, et al. Brain morphometric biomarkers distinguishing unipolar and bipolar depression: a voxel-based morphometry-pattern classification approach. JAMA Psychiatry. 2014;71(11):1222\u201330.","DOI":"10.1001\/jamapsychiatry.2014.1100"},{"key":"541_CR102","unstructured":"Pinato L, et al. Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis. Brain Struct Funct. In press."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-014-0541-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-014-0541-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-014-0541-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:46:55Z","timestamp":1559422015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-014-0541-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s11920-014-0541-1","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]},"article-number":"8"}}